Results 161 to 170 of about 7,411 (220)

Quality of antidiabetic medicines in 13 sub-Saharan African countries: a cross-sectional survey. [PDF]

EClinicalMedicine
Antignac M, N'Guetta R, Secretan PH, Do B, Ikama MS, Mipinda JB, Toure IA, Takombe JL, Lubenga Y, Dia MM, Isselmou Boukhary Ould EB, Dalaba M, Balde NM, Kake A, Sy ECI, Cavagna P, Perier MC, Sobngwi E, Cisse PB, Boitard C, Empana JP, Diop IB, Mbaye MN, Jouven X.   +23 more
europepmc   +1 more source

Management of Endocrinopathies During Pregnancy: A Systematic Review. [PDF]

Cureus
Kirovakov Z, Gyokova E, Hinkova N, Stoilov B.   +3 more
europepmc   +1 more source

Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical Trial.

JAMA
Rademaker D, de Wit L, Duijnhoven RG, Voormolen DN, Mol BW, Franx A, DeVries JH, Painter RC, van Rijn BB, SUGAR-DIP Study Group, Siegelaar SE, Akerboom BMC, Kiewiet-Kemper RM, Verwij-Didden MAL, Assouiki F, Kuppens SM, Oosterwerff MM, Stekkinger E, Diekman MJM, Vogelvang TE, Belle-van Meerkerk G, Galjaard S, Verdonk K, Lub A, Klooker TK, Krabbendam I, van Wijk JPH, Huisjes AJM, van Bemmel T, Nijman RGW, van den Beld AW, Hermes W, Johannsson-Vidarsdottir S, Vlug AG, Dullemond RC, Jansen HJ, Sueters M, de Koning EJP, van Laar JOEH, Wouters-van Poppel P, Evers IM, Sanson-van Praag ME, van den Akker ES, Brouwer CB, Hermsen BB, Scholten R, Meijer RI, van Leeuwen M, Wijbenga JAM, Wijnberger LDE, van Bon AC, van der Made FW, Eskes SA, Zandstra M, van Houtum WH, Braams-Lisman BAM, Daemen-Gubbels CRGM, Nijkamp JW, de Valk HW, Wouters MGAJ, IJzerman RG, Reiss I, van der Post JAM, Bosmans JE.   +63 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Glyburide-Induced Hepatitis

Annals of Internal Medicine, 1987
Drug-induced hepatotoxicity, although common, has been reported only infrequently with sulfonylureas. For glyburide, a second-generation sulfonylurea, only two brief reports of hepatotoxicity exist. Two patients with type II diabetes mellitus developed an acute hepatitis-like syndrome soon after initiation of glyburide therapy.
R C, Goodman, P J, Dean, A, Radparvar, A E, Kitabchi   +3 more
openaire   +2 more sources

Is Glyburide Safe in Pregnancy?

Current Pharmaceutical Biotechnology, 2014
The clinical recognition and adequate treatment of women with hyperglycemia during pregnancy is significant in order to reduce neonatal complications correlated with gestational diabetes mellitus (GDM). The traditional management of pregnant patients with GDM in whom diet restriction is not sufficient enough involves subcutaneous insulin administration.
Żaneta, Kimber-Trojnar, Beata, Marciniak, Jolanta, Patro-Malysza, Katarzyna, Skorzynska-Dziduszko, Elzbieta, Poniedzialek-Czajkowska, Radzislaw, Mierzynski, Krzysztof, Galczynski, Marcin, Trojnar, Bozena, Leszczynska-Gorzelak, Jan, Oleszczuk   +9 more
openaire   +3 more sources

Pharmacokinetics of glyburide

The American Journal of Medicine, 1985
The pharmacokinetics of glyburide can be described by a two-compartment open model. Terminal-phase descriptions are formulation-dependent and are complicated by apparent food-associated mobilization of drug from the stomach. Some researchers indicate a possible third (or deep) compartment, but this appears to be an artifact of a nonspecific drug assay.
openaire   +2 more sources

Hypoglycemia From Glipizide and Glyburide

JAMA, 1998
Hypoglycemia from glipizide and ...
Gambassi, Giovanni, Carbonin, Pierugo, Bernabei, Roberto   +2 more
openaire   +2 more sources

The inotropic action of tolbutamide and glyburide

Clinical Pharmacology and Therapeutics, 1989
The effect of glyburide on myocardial function in human beings is not known. We divided 37 normal male volunteers into five groups. Each group received either intravenous saline solution; 10 mg propranolol by intravenous push followed by 0.1 mg/min; 5 micrograms/kg/min dobutamine; 1000 mg or 1250 mg oral tolbutamide; or 5 mg glyburide.
M A, Rothschild, A H, Rothschild, M A, Pfeifer   +2 more
openaire   +2 more sources

Granulomatous hepatitis associated with glyburide

Digestive Diseases and Sciences, 1996
A wide variety of diseases and injuries can cause granulomatous hepatitis, and drug-induced granulomatous hepatitis is a well-described entity. Sulfonylurea derivatives, which are commonly used oral hypoglycemic agents in the treatment of non-insulin-dependent diabetes mellitus, have been implicated in liver disease.
D, Saw, E, Pitman, M, Maung, P, Savasatit, D, Wasserman, C K, Yeung   +5 more
openaire   +2 more sources